Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.28M | -6.15M | -6.10M | -6.27M | -8.00M |
| Total Depreciation and Amortization | 345.50K | 338.30K | 494.30K | 508.20K | 1.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.22M | 3.15M | -1.63M | -1.68M | 953.50K |
| Change in Net Operating Assets | -1.91M | -1.87M | -- | -- | 2.32M |
| Cash from Operations | -4.62M | -4.53M | -7.24M | -7.44M | -3.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -393.00K | -384.90K | 976.70K | 1.00M | -105.40K |
| Cash from Investing | -393.00K | -384.90K | 976.70K | 1.00M | -105.40K |
| Total Debt Issued | -- | -- | -- | -- | 2.20M |
| Total Debt Repaid | 0.00 | 0.00 | -950.00K | -950.00K | -1.10M |
| Issuance of Common Stock | 4.07M | 4.07M | 22.92M | 22.92M | 13.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 343.70K | 343.70K | -3.67M | -3.67M | -758.10K |
| Cash from Financing | 2.83M | 2.77M | 11.93M | 12.26M | 9.30M |
| Foreign Exchange rate Adjustments | -155.90K | -152.60K | 153.70K | 158.10K | -4.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.34M | -2.30M | 5.82M | 5.98M | 5.50M |